Chemocentryx reported $454.84M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Bayer BAYN:GR € 116549M 2122M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bristol Myers Squibb BMY:US $ 110893M 96M
Chemocentryx CCXI:US $ 454.84M 12.83M
GlaxoSmithKline GSK:LN 78689M 1678M
Glaxosmithkline GSK:US $ 78689M 1678M
Macrogenics MGNX:US $ 392.16M 33.75M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Novartis NOVN:VX SF 121209M 2806M
Omeros OMER:US $ 123.43M 21.96M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Takeda 4502:JP Y 12560273M 96961M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B
YTE INCY:US $ 4198.83M 294.21M